Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finotonlimab Combined With Chemotherapy as Perioperative Therapy for Stage II HNSCC
NCT07751276Phase 2Not yet recruiting
- Start
- Aug 2026
- Primary completion
- Dec 2029
01
Overview
A Phase 2 trial of finotonlimab in head and neck squamous cell carcinoma (HNSCC). Planned start Aug 2026; status: not yet recruiting.
02
Drugs
finotonlimab
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT07751276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07751276.